Effectiveness of Virgin Coconut Oil and Regular Repositioning in Preventing Pressure Ulcers in Children

R P Andayani1, F Wahyuni1, R Ausrianti1

  • 1STIKes MERCUBAKTIJAYA Padang, Indonesia.

PubMed

Insights

Virgin Coconut Oil (VCO) and regular repositioning significantly reduce pressure ulcer risk. This study demonstrates the effectiveness of these interventions in improving skin integrity and preventing pressure sores.

Area of Science:

  • Nursing
  • Dermatology
  • Preventive Medicine

Background:

  • Pressure ulcers negatively impact patient health.
  • Early detection of skin integrity damage is crucial for prevention.
  • Virgin Coconut Oil (VCO) offers antioxidant and vitamin E benefits for skin health.

Purpose of the Study:

  • To evaluate the effectiveness of Virgin Coconut Oil (VCO) and regular repositioning in preventing pressure ulcers.
  • To assess the impact of these interventions on skin integrity.
  • To provide evidence for non-pharmacological pressure ulcer prevention strategies.

Main Methods:

  • Quasi-experimental pretest-posttest nonequivalent control group design.
  • 86 participants selected via consecutive nonprobability sampling.
  • Intervention group received VCO; control group received repositioning.

Main Results:

  • A statistically significant difference (p<0.001) was observed in Braden QD scores before and after interventions.
  • Both VCO and repositioning interventions showed positive effects on preventing pressure ulcers.

Conclusions:

  • Nurses should utilize the Braden QD Scale for early detection of skin integrity issues.
  • Implementing Virgin Coconut Oil (VCO) and regular repositioning is recommended for pressure ulcer prevention.
  • These interventions represent effective nursing strategies for maintaining skin integrity.
Abstract

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
500
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
558
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
340
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
12
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
519